Showing results (1-10 of 723) with videos related to
Sort By:
Pageof 73
Future Oncology (London, England)|February 16, 2023
Afatinib for the treatment of non-small-cell lung cancer with unusual EGFR mutations: a plain language summaryJames Chih-Hsin YangCancer Research and Treatment|July 27, 2019
Osimertinib in Patients with T790M-Positive Advanced Non-small Cell Lung Cancer: Korean Subgroup Analysis from Phase II StudiesMyung-Ju Ahn, Ji-Youn Han, Dong-Wan Kim, et al.Lung Cancer (Amsterdam, Netherlands)|February 14, 2026
Overall survival for amivantamab plus lazertinib versus osimertinib as first-line treatment in Asian participants with EGFR-mutant advanced NSCLC: A MARIPOSA subset analysisHidetoshi Hayashi, Byoung Chul Cho, Yu Jung Kim, et al.Lung Cancer (Amsterdam, Netherlands)|December 11, 2025
MAGELLAN arms B1 and B3: Durvalumab plus chemotherapy with and without oleclumab in treatment-naïve metastatic non-small-cell lung cancerByoung Chul Cho, Chaiyut Charoentum, Dong-Wan Kim, et al.Drugs|December 24, 2010
Optimal management of patients with non-small cell lung cancer and epidermal growth factor receptor mutationsChia-Chi Lin, James Chih-Hsin YangCancer Cell|February 13, 2024
Re-inventing a better wheel? Serplulimab for squamous cell lung cancerDerek De-Rui Huang, James Chih-Hsin YangYonsei Medical Journal|August 29, 2022
Lazertinib: on the Way to Its ThroneJiyun Lee, Min Hee Hong, Byoung Chul ChoJournal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 30, 2026
Long-Term Impact of First-Line Amivantamab Plus Lazertinib Versus Osimertinib on Mechanisms of Acquired Resistance in MARIPOSA: A Brief ReportHidetoshi Hayashi, Byoung Chul Cho, David R Spigel, et al.Anticancer Research|March 31, 2021
CD73 Is Regulated by the EGFR-ERK Signaling Pathway in Non-small Cell Lung CancerSebastian Griesing, Bin-Chi Liao, James Chih-Hsin YangTherapeutic Advances in Medical Oncology|December 6, 2019
Second-line treatment of EGFR T790M-negative non-small cell lung cancer patientsBin-Chi Liao, Sebastian Griesing, James Chih-Hsin YangPageof 73